Intuitive Surgical shares jump after beating Q4 expectations

The robotic surgery pioneer posted adjusted earnings per share of $2.53, significantly above the analyst consensus of $2.26. Revenue climbed to $2.87 billion, exceeding the $2.75 billion estimate and marking a 19% increase compared to $2.41 billion in the same quarter last year. The strong performance was driven by a 17% growth in da Vinci procedures and a 44% jump in Ion procedures.

"Our fourth quarter results reflect continued global adoption of our minimally invasive robotic platforms," said Gary Guthart, CEO of Intuitive Surgical. "The placement of 303 da Vinci 5 systems this quarter demonstrates strong customer reception to our newest surgical system."

The company placed 532 da Vinci surgical systems in the quarter, up from 493 in the year-ago period, growing its installed base to 11,106 systems, a 12% YoY increase. Instruments and accessories revenue rose 17% to $1.66 billion, while systems revenue reached $786 million compared to $655 million a year earlier.

Looking ahead, Intuitive Surgical provided guidance for 2026, projecting worldwide da Vinci procedure growth of approximately 13% to 15%, compared to 18% in 2025. The company expects non-GAAP gross profit margin to be between 67% and 68% of revenue, which includes an estimated 1.2% impact from tariffs.

The company ended the quarter with a strong financial position, reporting $9.03 billion in cash, cash equivalents, and investments, an increase of $600 million during the quarter.

You May Also Be Interested In

• Bath & Body Works rises as Citi upgrades stock ahead of earnings
• Harvard discloses $2.2B SpaceX stake, over half its U.S. equity portfolio
• Micron rises as White House presses Apple to avoid Chinese memory chips